CREB1 and Alzheimer disease: Apigenin has been shown to ameliorate AD-associated cognitive deficits in APP/PS1 double transgenic AD mice by reducing amyloid-β peptides accumulation, inhibiting oxidative stress, and restoring ERK/CREB/BDNF pathway [94].